Literature DB >> 28860067

A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.

Altan Rentsendorj1, Julia Sheyn1, Dieu-Trang Fuchs1, David Daley1, Brenda C Salumbides1, Hannah E Schubloom1, Nadav J Hart1, Songlin Li2, Eric Y Hayden3, David B Teplow3, Keith L Black1, Yosef Koronyo1, Maya Koronyo-Hamaoui4.   

Abstract

Osteopontin (OPN), a matricellular immunomodulatory cytokine highly expressed by myelomonocytic cells, is known to regulate immune cell migration, communication, and response to brain injury. Enhanced cerebral recruitment of monocytes achieved through glatiramer acetate (GA) immunization or peripheral blood enrichment with bone marrow (BM)-derived CD115+ monocytes (MoBM) curbs amyloid β-protein (Aβ) neuropathology and preserves cognitive function in murine models of Alzheimer's disease (ADtg mice). To elucidate the beneficial mechanisms of these immunomodulatory approaches in AD, we focused on the potential role of OPN in macrophage-mediated Aβ clearance. Here, we found extensive OPN upregulation along with reduction of vascular and parenchymal Aβ burden in cortices and hippocampi of GA-immunized ADtg mice. Treatment combining GA with blood-grafted MoBM further increased OPN levels surrounding residual Aβ plaques. In brains from AD patients and ADtg mice, OPN was also elevated and predominantly expressed by infiltrating GFP+- or Iba1+-CD45high monocyte-derived macrophages engulfing Aβ plaques. Following GA immunization, we detected a significant increase in a subpopulation of inflammatory blood monocytes (CD115+CD11b+Ly6Chigh) expressing OPN, and subsequently, an elevated population of OPN-expressing CD11b+Ly6C+CD45high monocyte/macrophages in the brains of these ADtg mice. Correlogram analyses indicate a strong linear correlation between cerebral OPN levels and macrophage infiltration, as well as a tight inverse relation between OPN and Aβ-plaque burden. In vitro studies corroborate in vivo findings by showing that GA directly upregulates OPN expression in BM-derived macrophages (MФBM). Further, OPN promotes a phenotypic shift that is highly phagocytic (increased uptake of Aβ fibrils and surface scavenger receptors) and anti-inflammatory (altered cell morphology, reduced iNOS, and elevated IL-10 and Aβ-degrading enzyme MMP-9). Inhibition of OPN expression in MФBM, either by siRNA, knockout (KOOPN), or minocycline, impairs uptake of Aβ fibrils and hinders GA's neuroprotective effects on macrophage immunological profile. Addition of human recombinant OPN reverses the impaired Aβ phagocytosis in KOOPN-MФBM. This study demonstrates that OPN has an essential role in modulating macrophage immunological profile and their ability to resist pathogenic forms of Aβ.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ETA-1; Neurodegeneration; Neuroinflammation; SPP1; Vascular amyloid

Mesh:

Substances:

Year:  2017        PMID: 28860067      PMCID: PMC5865478          DOI: 10.1016/j.bbi.2017.08.019

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   19.227


  62 in total

1.  Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke.

Authors:  Michael Gliem; Kristina Krammes; Lucy Liaw; Nico van Rooijen; Hans-Peter Hartung; Sebastian Jander
Journal:  Glia       Date:  2015-07-07       Impact factor: 7.452

2.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

3.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Authors:  Kenneth E Bernstein; Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Dahabada H J Lopes; Kandarp H Shah; Ellen A Bernstein; Dieu-Trang Fuchs; Jeff J-Y Yu; Michael Pham; Keith L Black; Xiao Z Shen; Sebastien Fuchs; Maya Koronyo-Hamaoui
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

4.  Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline.

Authors:  Cristoforo Comi; Miryam Carecchio; Annalisa Chiocchetti; Stefania Nicola; Daniela Galimberti; Chiara Fenoglio; Giuseppe Cappellano; Francesco Monaco; Elio Scarpini; Umberto Dianzani
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.

Authors:  Oleg Butovsky; Maya Koronyo-Hamaoui; Gilad Kunis; Eran Ophir; Gennady Landa; Hagit Cohen; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 6.  Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

Authors:  Martin C Herzig; William E Van Nostrand; Mathias Jucker
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

7.  Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease.

Authors:  Dan Frenkel; Ruth Maron; David S Burt; Howard L Weiner
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

8.  Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice.

Authors:  Ravid Shechter; Anat London; Chen Varol; Catarina Raposo; Melania Cusimano; Gili Yovel; Asya Rolls; Matthias Mack; Stefano Pluchino; Gianvito Martino; Steffen Jung; Michal Schwartz
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

9.  Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9.

Authors:  Maya Koronyo-Hamaoui; Minhee K Ko; Yosef Koronyo; David Azoulay; Akop Seksenyan; Gilad Kunis; Michael Pham; Joshua Bakhsheshian; Patricia Rogeri; Keith L Black; Daniel L Farkas; Michal Schwartz
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

Review 10.  Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.

Authors:  Leah Zuroff; David Daley; Keith L Black; Maya Koronyo-Hamaoui
Journal:  Cell Mol Life Sci       Date:  2017-02-14       Impact factor: 9.261

View more
  35 in total

1.  Patterns of Osteopontin Expression in Abusive Head Trauma Compared with Other Causes of Pediatric Traumatic Brain Injury.

Authors:  Laura S Blackwell; Margaret Martinez; Ashley Fournier-Goodnight; Janet Figueroa; Andrew Appert; Atul Vats; Bushra Wali; Iqbal Sayeed; Andrew Reisner
Journal:  J Pediatr       Date:  2020-07-02       Impact factor: 4.406

2.  Plasma osteopontin may predict neuroinflammation and the severity of pediatric traumatic brain injury.

Authors:  Ning Gao; Xiaohui Zhang-Brotzge; Bushra Wali; Iqbal Sayeed; Joshua J Chern; Laura S Blackwell; Chia-Yi Kuan; Andrew Reisner
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-13       Impact factor: 6.200

3.  Maternal immune activation alters fetal and neonatal microglia phenotype and disrupts neurogenesis in mice.

Authors:  Marco Loayza; Shuying Lin; Kathleen Carter; Norma Ojeda; Lir-Wan Fan; Sumana Ramarao; Abhay Bhatt; Yi Pang
Journal:  Pediatr Res       Date:  2022-08-13       Impact factor: 3.953

4.  Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.

Authors:  Maya Koronyo-Hamaoui; Julia Sheyn; Eric Y Hayden; Songlin Li; Dieu-Trang Fuchs; Giovanna C Regis; Dahabada H J Lopes; Keith L Black; Kenneth E Bernstein; David B Teplow; Sebastien Fuchs; Yosef Koronyo; Altan Rentsendorj
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

5.  Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke.

Authors:  Ligen Shi; Zeyu Sun; Wei Su; Fei Xu; Di Xie; Qingxiu Zhang; Xuejiao Dai; Kartik Iyer; T Kevin Hitchens; Lesley M Foley; Sicheng Li; Donna B Stolz; Kong Chen; Ying Ding; Angus W Thomson; Rehana K Leak; Jun Chen; Xiaoming Hu
Journal:  Immunity       Date:  2021-05-19       Impact factor: 43.474

6.  Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.

Authors:  Gajanan Sathe; Marilyn Albert; Jacqueline Darrow; Atsushi Saito; Juan Troncoso; Akhilesh Pandey; Abhay Moghekar
Journal:  J Neurochem       Date:  2020-07-22       Impact factor: 5.546

7.  Characterisation of Osteopontin in an In Vitro Model of Embryo Implantation.

Authors:  Stéphane C Berneau; Peter T Ruane; Daniel R Brison; Susan J Kimber; Melissa Westwood; John D Aplin
Journal:  Cells       Date:  2019-05-09       Impact factor: 6.600

Review 8.  Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders.

Authors:  Hongzhen Chen; Dewei Shang; Yuguan Wen; Chao Liang
Journal:  Front Cell Dev Biol       Date:  2021-06-10

9.  Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ42 Assemblies.

Authors:  Leah R Zuroff; Tania Torbati; Nadav J Hart; Dieu-Trang Fuchs; Julia Sheyn; Altan Rentsendorj; Yosef Koronyo; Eric Y Hayden; David B Teplow; Keith L Black; Maya Koronyo-Hamaoui
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

10.  Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.

Authors:  Hila Ben-Yehuda; Michal Arad; Javier María Peralta Ramos; Efrat Sharon; Giulia Castellani; Shir Ferrera; Liora Cahalon; Sarah Phoebeluc Colaiuta; Tomer-Meir Salame; Michal Schwartz
Journal:  Mol Neurodegener       Date:  2021-06-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.